Abstract
How do we best constrain social interactions to prevent the transmission of communicable respiratory diseases? Indiscriminate suppression, the currently accepted answer, is both unsustainable long term and implausibly presupposes all interactions to carry equal weight. Transmission within a social network is determined by the topology of its graphical structure, of which the number of interactions is only one aspect. Here we deploy large-scale numerical simulations to quantify the impact on pathogen transmission of a set of topological features covering the parameter space of realistic possibility. We first test through a series of stochastic simulations the differences in the spread of disease on several classes of network geometry (including highly skewed networks and small world). We then aim to characterise the spread based on the characteristics of the network topology using regression analysis, highlighting some of the network metrics that influence the spread the most. For this, we build a dataset composed of more than 9000 social networks and 30 topological network metrics. We find that pathogen spread is optimally reduced by limiting specific kinds of social contact – unfamiliar and long range – rather than their global number. Our results compel a revaluation of social interventions in communicable diseases, and the optimal approach to crafting them.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵∗ Email: maria.perez{at}ucl.ac.uk
Data Availability
The data is generated via simulations. The code and dataset will be made available at https://github.com/mperezortiz/topology_spread
